The estimated Net Worth of Michael J Glennon is at least $421 Thousand dollars as of 5 December 2022. Mr. Glennon owns over 250,000 units of PAVmed Inc stock worth over $395,000 and over the last 9 years he sold PAVM stock worth over $0. In addition, he makes $26,250 as Independent Vice Chairman of the Board at PAVmed Inc.
Sign up
Mr. Glennon PAVM stock SEC Form 4 insiders trading
Michael has made over 1 trades of the PAVmed Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently he bought 250,000 units of PAVM stock worth $160,000 on 5 December 2022.
The largest trade he's ever made was buying 250,000 units of PAVmed Inc stock on 5 December 2022 worth over $160,000. On average, Michael trades about 16,667 units every 0 days since 2016. As of 5 December 2022 he still owns at least 250,000 units of PAVmed Inc stock.
You can see the complete history of Mr. Glennon stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Michael Glennon biography
Michael J. Glennon serves as Independent Vice Chairman of the Board of the Company. Mr. Glennon has served as a co-founding Partner of both PHG and PMI since their respective inceptions in 2007 and 2009 and also serves as Chairman and Chief Executive Officer of PMI. Mr. Glennon has served as President, Chief Executive Officer and a director of Saphena Medical since February 2013 and Cruzar Medsystems since July 2013 and as a director of Kaleidoscope Medical since January 2013. Mr. Glennon was the President and Chief Executive Officer of Vortex Medical from its inception in 2008 until its acquisition in October 2012 by AngioDynamics. From 2005 to 2007, Mr. Glennon was Senior Vice President - Sales and Marketing for Accellent Inc., a market-leading provider of outsourced precision manufacturing and engineering services to the medical device industry. Accellent was a portfolio company of DLJ Merchant Banking Partners and was acquired in 2005 by KKR and Bain Capital. From 2004 to 2005, Mr. Glennon was a Cardiac Rhythm Management District Manager at Medtronic. From 1996 to 2004, Mr. Glennon was a Sales Manager at Guidant including seven years at Guidant Cardiac Surgery (now, Maquet Cardiovascular). He was instrumental in the launch and rapid growth of VasoView, the first endoscopic vessel harvesting technology, which became the standard of care in coronary bypass surgery. From 1993 to 1995, Mr. Glennon worked for Origin Medsystems which was acquired by Eli Lilly and subsequently spun out as part of Guidant. Previously, Mr. Glennon was with Stryker Endoscopy and Storz Instrument Company. Mr. Glennon received his B.S. in Business Administration from the University of New Hampshire.
What is the salary of Michael Glennon?
As the Independent Vice Chairman of the Board of PAVmed Inc, the total compensation of Michael Glennon at PAVmed Inc is $26,250. There are 10 executives at PAVmed Inc getting paid more, with Dr. Lishan Aklog M.D. having the highest compensation of $686,300.
How old is Michael Glennon?
Michael Glennon is 54, he's been the Independent Vice Chairman of the Board of PAVmed Inc since 2014. There are 8 older and no younger executives at PAVmed Inc. The oldest executive at PAVmed Inc is James Cox, 77, who is the Independent Director.
What's Michael Glennon's mailing address?
Michael's mailing address filed with the SEC is 360 MADISON AVENUE, 25TH FLOOR, NEW YORK, NY, 10017.
Insiders trading at PAVmed Inc
Over the last 9 years, insiders at PAVmed Inc have traded over $1,291,924 worth of PAVmed Inc stock and bought 370,262 units worth $523,987 . The most active insiders traders include Ira Scott Greenspan, Matthew Sirovich, and Michael J Glennon. On average, PAVmed Inc executives and independent directors trade stock every 73 days with the average trade being worth of $62,625. The most recent stock trade was executed by Michael J Glennon on 5 December 2022, trading 250,000 units of PAVM stock currently worth $160,000.
What does PAVmed Inc do?
pavmed is a groundbreaking medical device company bringing innovative medical technologies from concept to commercialization with unprecedented speed and efficiency. led by three accomplished medical device entrepreneurs and organized to conceive, develop and commercialize a diversified pipeline of innovative products we believe address unmet clinical needs, our goal is to enhance and accelerate value creation by employing a business model focused on capital and time efficiency.
What does PAVmed Inc's logo look like?
Complete history of Mr. Glennon stock trades at PAVmed Inc
PAVmed Inc executives and stock owners
PAVmed Inc executives and other stock owners filed with the SEC include:
-
Dr. Lishan Aklog M.D.,
Chairman & CEO -
Lishan Aklog,
Chairman of the Board, Chief Executive Officer -
Dennis M. McGrath CPA,
Pres, CFO & Corp. Sec. -
Dennis McGrath,
President, Chief Financial Officer and Corporate Secretary -
Brian DeGuzman,
Executive Vice President - Clinical Affairs, Chief Medical Officer -
Dr. Brian J. deGuzman M.D.,
Chief Medical Officer & Exec. VP of Clinical Affairs -
David Weild,
Independent Director -
Ronald Sparks,
Independent Director -
David Battleman,
Independent Director -
James Cox,
Independent Director -
Michael Glennon,
Independent Vice Chairman of the Board -
Mike Havrilla,
Director of Investor Relations -
Sunny Webb,
VP, Data & Analytics -
James Mitchell M.D.,
VP of Digital Health -
Shaun M. O'Neil,
Chief Commercial Officer -
Ira Scott Greenspan,
Director -
Joshua R Lamstein,
Director -
Richard F Fitzgerald,
CFO and Secretary -
Lishan Pavilion Venture Par...,
Chairman and CEO -
Matthew Sirovich,
10% owner -
Joan B Harvey,
Director -
Shaun O'neil,
Chief Operating Officer -
Debra White,
Director -
Lishan Aklog,
Chairman and CEO -
Timothy E Baxter,
Director -
Michael Adam Gordon,
General Counsel